Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.26, $0.08 better than the analyst estimate of $0.18. Revenue for the quarter came in at $167.5 million versus the consensus estimate of $162 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2025 EPS of $0.75-$0.95, versus the consensus of $1.13. Avanos Medical, Inc. sees FY2025 revenue of $665-685 million, versus the consensus of $673.5 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.